FIELD: medicine.
SUBSTANCE: that is ensured by measuring peripheral blood anti-cytomegalovirus antibody titre, placental homogenate S-phospholipase A2 by immunoassay and apoptotic nuclear count in placental plasmodium. If the anti-cytomegalovirus antibody titre tends to increase to 1:1600, whereas placental homogenate S-phospholipase A2 increases to 12.0 ng/ml, and the apoptotic nuclear count in placental plasmodium - to 3.0%, a risk of the damaged fetoplacental barrier of placental villi is created.
EFFECT: method enables assessing the risk of the damaged fetoplacental barrier accompanying the cytomegalovirus infection in the third trimester of gestation by an increase of S-phospholipase A2 and in the apoptotic nuclear count in placental plasmodium.
Authors
Dates
2015-10-27—Published
2014-06-03—Filed